Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.
about
Ketamine: 50 Years of Modulating the MindKetamine Suppresses the Ventral Striatal Response to Reward Anticipation: A Cross-Species Translational Neuroimaging Study.Vitamin D Deficiency and Depressive Symptomatology in Psychiatric Patients Hospitalized with a Current Depressive Episode: A Factor Analytic Study.Reliability of 7T (1) H-MRS measured human prefrontal cortex glutamate, glutamine, and glutathione signals using an adapted echo time optimized PRESS sequence: A between- and within-sessions investigation.Overview of Glutamatergic Dysregulation in Central Pathologies.Hedonic sensitivity to low-dose ketamine is modulated by gonadal hormones in a sex-dependent mannerDisrupted habenula function in major depressionTargeting glutamate signalling in depression: progress and prospects.Ketamine for treatment-resistant depression: recent developments and clinical applications.Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine.Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder.The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.Affective Processing in Non-invasive Brain Stimulation Over Prefrontal Cortex.Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders.Altered interaction with environmental reinforcers in major depressive disorder: Relationship to anhedonia.Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world study.Molecular Mechanism and Clinical Relevance of Ketamine as Rapid-Acting Antidepressant.The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature.Glutamatergic Modulators in Depression.Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales.Mechanisms of ketamine action as an antidepressant.Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.
P2860
Q28077524-9A02EFD5-9EDE-4E55-845C-795FDF3D0F6EQ30359978-75123008-8A11-45A5-9122-F7E3AEADB76AQ35784556-735AFCF8-E973-473C-A012-E5975DB7F2B8Q36352405-24190358-EAD5-4D1D-8D09-BAFCF74CA973Q36409596-58C80BFF-8F74-42B8-9C77-A3BC8DF86E8EQ36616952-CE404D7D-29AA-4A1C-9287-2547C58C32DEQ37617589-3967D573-EAD2-4D8B-97CE-A4F860587986Q38743867-1A01B713-D7F4-46F7-8AD0-4B1FCB94B8C3Q38800172-EEBF4F20-70CC-4E76-A89C-94F2EDFDB878Q38800909-49598D4D-B6F1-4023-ADFA-09D092418D06Q38837851-0F9AE1BC-110C-4D75-9ADE-202EF5A01BE6Q38838637-E25F5D95-61C5-497B-A52E-618A06DE0412Q39642484-9B822BDA-19CC-414F-BFBB-CF2046353D73Q39758341-0C1FB89E-0A38-440E-9452-B611D5D852DCQ41237129-4AB2A7D6-F00A-41A0-A062-E565B27DDAE7Q42253326-E38815B1-C463-4920-86AA-FE3A77ECFCE7Q42253328-6118B0CB-9539-48B9-A9C8-79EE809655A4Q47371574-C4C6C93E-515A-4EBF-BC97-87AE869BD9ADQ47396901-D8167A03-E3F6-4BDC-A681-F8F098F5DCEDQ47597246-A100B858-387C-4E8D-8FE9-2F7711FE9C0BQ49712840-3CBAA3FA-EB57-445A-A183-DB42C5DC49DEQ49712849-2B58FC36-1892-46BB-A33D-5F7DE24059B7Q49967356-8A106A7D-3743-4C42-8C71-6A20502B3AC4Q52658612-6261C0C8-4566-45CA-AD3A-6FC684AD7BFEQ55438088-2DFA1AAB-DB71-4C5E-AA57-FCE7514FEA6E
P2860
Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 February 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neural correlates of change in ...... following open-label ketamine.
@en
Neural correlates of change in ...... following open-label ketamine.
@nl
type
label
Neural correlates of change in ...... following open-label ketamine.
@en
Neural correlates of change in ...... following open-label ketamine.
@nl
prefLabel
Neural correlates of change in ...... following open-label ketamine.
@en
Neural correlates of change in ...... following open-label ketamine.
@nl
P2093
P2860
P50
P356
P1476
Neural correlates of change in ...... following open-label ketamine.
@en
P2093
Carlos A Zarate
David A Luckenbaugh
Níall Lally
P2860
P304
P356
10.1177/0269881114568041
P407
P577
2015-02-17T00:00:00Z